CENTOGENE Enrolls First Patient in Frontotemporal Dementia (FTD) Clinical Study
FTD is a rapidly progressing neurodegenerative disease; up to 30% of all cases worldwide caused by genetic mutations, including the progranulin gene mutation (FTD-GRN)Study will enroll and…